Lexpos News

Community Pharmacy England met in London on 19th and 20th November, with Committee members considering preparations for the next round of Community Pharmacy Contractual Framework (CPCF) negotiations, ongoing financial pressures, winter readiness and other important matters. Closing the sector’s longstanding funding gap and addressing operational pressures remain the central focus of the Committee. There has [...]

The post Upcoming CPCF negotiations the focus at November meeting appeared first on Community Pharmacy England.

The NHSmail programme is being rebranded to NHS.net Connect. This change, announced previously, introduces a refreshed look and new features. Your existing NHS.net email address, login details, and helpdesk support will remain the same. Some NHS.net users will soon see a refreshed homepage and improved features designed to make communication across the NHS easier. The [...]

The post NHSmail becoming NHS.net Connect: New Launchpad homepage coming soon appeared first on Community Pharmacy England.

In recent months, Community Pharmacy England has received a number of concerns about EPS pharmacy nominations and re-nominations without patient consent, and wishes to remind pharmacy owners of the relevant Terms of Service requirements and the importance of patient choice of nominated pharmacy. Terms of Service The Terms of Service provide that a pharmacy owner [...]

The post Respecting Patient Choice for Pharmacy EPS Nominations appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (28/11/2025) confirmed the following list of price concessions for November 2025: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department. [...]

The post November 2025 Price Concessions – 6th Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 125mg/5ml oral suspension sugar free and Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP077 Cefalexin 125mg/5ml oral suspension sugar free and SSP078 Cefalexin 250mg/5ml oral suspension [...]

The post Expiry of SSP077 (Cefalexin 125mg/5ml oral suspension sugar free) & SSP078 (Cefalexin 250mg/5ml oral suspension sugar free) appeared first on Community Pharmacy England.